NewslettersImmunology of Infectious Disease News Development of a Pentavalent Broadly Protective Nucleoside-Modified mRNA Vaccine against Influenza B Viruses By Danielle Corrigan - August 9, 2022 0 Investigators focused on the development of a universal influenza B virus vaccine based on the lipid nanoparticle-encapsulated nucleoside-modified mRNA platform. [Nature Communications] Full Article